Outcomes in cardiogenic shock: the role of surrogate endpoints.

Kosyakovsky, Leah B; Marbach, Jeffrey A; Nguyen, Khoa; Mukundan, Srini; Chweich, Haval; Kapur, Navin K

Kosyakovsky, Leah B; Marbach, Jeffrey A; Nguyen, Khoa; Mukundan, Srini; Chweich, Haval; Kapur, Navin K.

Afiliação

Kosyakovsky LB; Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center.
Marbach JA; Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center.
Nguyen K; The Cardiogenic Shock Working Group, Tufts Medical Center, Boston, Massachusetts.
Mukundan S; Division of Cardiovascular Medicine, Oregon Health Sciences University Knight Cardiovascular Center, Portland, Oregon.
Chweich H; Division of Cardiovascular Medicine, Oregon Health Sciences University Knight Cardiovascular Center, Portland, Oregon.
Kapur NK; Department of Medicine.

Curr Opin Crit Care ; 28(4): 442-452, 2022 08 01.

Article em En | MEDLINE | ID: mdl-35757956

Assuntos

Coração Auxiliar; Choque Cardiogênico; Biomarcadores; Tomada de Decisão Clínica; Hemodinâmica; Humanos; Fatores de Risco; Choque Cardiogênico/terapia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Choque Cardiogênico / Coração Auxiliar Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Curr Opin Crit Care Assunto da revista: TERAPIA INTENSIVA Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google